When did Kiniksa Pharmaceuticals International, plc report Q4 2024 earnings?

Kiniksa Pharmaceuticals International, plc (KNSA) reported Q4 2024 earnings on February 25, 2025 before market open.

What were Kiniksa Pharmaceuticals International, plc's Q4 2024 revenue and EPS?

Kiniksa Pharmaceuticals International, plc reported revenue of $122.5M and diluted EPS of $-0.12 for Q4 2024.

Revenue missed the consensus estimate of $123.4M by $879.8K. EPS missed the consensus estimate of $-0.06 by $0.06.

You can read the 10-K periodic report (0001558370-25-001505) directly on SEC EDGAR. The filing index links above go to sec.gov.

Reported February 25, 2025 · Before market open

Revenue estimate$123.4M

EPS estimate-$0.06

Jul 28, 2026 (in a month)

Revenue estimate$226.6M

EPS estimate$0.30

Q4 2024$122.5MMiss by $879.8K

Q4 2024-$0.12Miss by $0.06

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

When did Kiniksa Pharmaceuticals International, plc report Q4 2024 earnings?: Kiniksa Pharmaceuticals International, plc (KNSA) reported Q4 2024 earnings on February 25, 2025 before market open.
What were Kiniksa Pharmaceuticals International, plc's Q4 2024 revenue and EPS?: Kiniksa Pharmaceuticals International, plc reported revenue of $122.5M and diluted EPS of $-0.12 for Q4 2024.
Did Kiniksa Pharmaceuticals International, plc beat estimates in Q4 2024?: Revenue missed the consensus estimate of $123.4M by $879.8K. EPS missed the consensus estimate of $-0.06 by $0.06.
Where can I find Kiniksa Pharmaceuticals International, plc's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001558370-25-001505) directly on SEC EDGAR. The filing index links above go to sec.gov.